Ligands to GM-CSF or GM-CSF-receptor for use in treatment of a haematologic malignancy in a patient having undergone allo-HCT

• 收藏
• 分享

专利权人:

Universität Zürich

发明人:

TUGUES, Sonia,BECHER, Burkhard

申请号：

AU2019224550

公开号：

AU2019224550A1

申请日:

2019.02.22

申请国别(地区):

AU

年份:

2020

代理人:

摘要：

Described herein is the use of a non-agonist ligand, particularly an antibody, specifically binding to GM-CSF or one of CD116, CD131 and the GM-CSF receptor composed of CD116 and CD131 for use in treatment of leukemia in a patient having undergone allo-HCT or in treatment of other complications arising as a consequence of hematopoietic cell transplantation from an immunologically non-identical donor.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/